CEL-SCI Co. (NYSEAMERICAN:CVM) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 526,760 shares, an increase of 14.0% from the November 30th total of 462,000 shares. Based on an average daily volume of 128,714 shares, the days-to-cover ratio is presently 4.1 days. Currently, 4.8% of the company’s stock are short sold.

Separately, Dawson James reissued a “neutral” rating on shares of CEL-SCI in a report on Monday, October 16th.

In other CEL-SCI news, Director Vicente Benjamin Asuncion sold 160,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 17th. The stock was sold at an average price of $0.39, for a total transaction of $62,400.00.

Shares of CEL-SCI (NYSEAMERICAN CVM) traded down $0.03 during trading on Wednesday, reaching $1.86. The company’s stock had a trading volume of 69,066 shares, compared to its average volume of 174,430. CEL-SCI has a fifty-two week low of $1.46 and a fifty-two week high of $4.50. The firm has a market cap of $23.61, a P/E ratio of -1.41 and a beta of -1.58.

ILLEGAL ACTIVITY NOTICE: “CEL-SCI Co. (CVM) Short Interest Update” was reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another site, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this story can be viewed at https://theolympiareport.com/2017/12/27/cel-sci-co-cvm-short-interest-update.html.

CEL-SCI Company Profile

CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines.

Receive News & Ratings for CEL-SCI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEL-SCI and related companies with MarketBeat.com's FREE daily email newsletter.